Growth Opportunities in the Global qPCR and dPCR Market, Forecast to 2023

Novel Applications in Oncology and Applied Sciences, Growing Research and Diagnostic Use in Developing Regions, and Automated Modular Workflows to Drive Growth

USD 4,950.00

* Required Fields

USD 4,950.00

PAY BY INVOICE

Be the first to review this product

Overview: PCR continues to be the gold standard for nucleic acid amplification by combining accuracy and efficacy that users across areas such as research, pharma & biotech, diagnostics as well as applied sciences depend upon. Such widespread usage continues to drive the industry, even protecting it to some extent from overall economic/market fluctuations. However, as the industry matures, companies are innovating across instrument technology, reagents, and software solutions in order to maintain a competitive edge. As leading markets such as the United States and Europe face cost pressures, companies are offering solutions around multiplexing and high throughput devices. Reagent manufacturers are focused on pr

Research Highlights

This study highlights the prominence of qPCR and dPCR globally, growth opportunities, competitive dynamics, regional assessment, as well as novel business models.

Segments:

  • The qPCR instrument segment has matured with manufacturers competing on the basis of factors such as pricing, ease of use, and accuracy. Manufacturers are offering capabilities such as multiplexing and modular capabilities—to seamlessly fit into the wider automated lab ecosystem—as users look to improve process efficiencies and control cost.
  • The PCR reagent segment emerges as the segment with the largest revenue driven by high consumption across device types. With improvements in instrument technology, reagents are also expected to innovate. For example, companies need to provide multiplexing-capable reagents kits that offer higher speed, efficacy, and lower processing time for multiple indications. Additionally, consumers demand custom as well as dry kits with primers and probes for specific targets.
  • While the dPCR instrument segment shows the fastest growth rate during our forecast range of 2018-2023, the high initial cost of the dPCR instrument continues to be a significant roadblock for its adoption with most users commenting that current qPCR devices are adequate to cater to their needs. However, manufacturers are driving usage in areas that require exact quantification capabilities and comparatively higher detection sensitivity, such as liquid biopsy. Companies are also launching dPCR instruments that attempt to mimic the high throughput capabilities of traditional qPCR instruments.
  • PCR software are used across the PCR processing value chain including primer design, sample preparation, process management, as well as final result analysis. While device manufacturers provide the software, a variety of independent software platforms are available as well. Software vendors are offering value-add capabilities such as laboratory information management system (LIMS) connectivity and transfer, data management, and auditing capabilities. Companies such as UgenTec offer an AI-powered automated solutions for analysis of high-volume PCR data to reduce the need of human intervention.

Companies such as Thermo Fisher, Bio-Rad, Roche, Qiagen, and Agilent emerge as leading players in the qPCR as well as the reagents segments. However, the reagents segment is highly fragmented towards the tail end as many devices can run reagents/kits from multiple manufacturers and users tend to use reagents/kits as per their personal criteria. The dPCR instrument segment shows the fastest growth, with Bio-Rad and Thermo Fisher emerging as leading companies in this space.

Areas of opportunities:

  • PCR application in Liquid Biopsy: Liquid biopsy techniques for tumor profiling and treatment monitoring applications using biomarkers comprising circulating tumor DNA (ctDNA) are likely to be an emerging application area
  • AI to Automate PCR Processes and Analysis: Wide use of PCR is creating huge data sets, hence high-volume labs are looking for solutions that can automate the process as well as help in the management and analysis of data.
  • Companion Diagnostics (CDx) and Precision Medicine: Novel PCR methodologies such as dPCR can offer accuracy and reproducibility— key for correct prognosis and diagnosis in precise CDx solutions.
  • Multiplexing and Miniaturization: With high cost of lab consumables, multiplexing helps in running multiple processes simultaneously, whereas miniaturized devices help widen device and solutions access at lower costs.
  • Novel Application and Methodologies: Novel detection procedures, combination methodologies, as well as non-traditional areas of application are likely to drive growth in areas such as forensics, nutrition sciences, agriculture, and veterinary sciences.

Regional:

Traditional growth markets such as the United States and Europe have matured and growth is expected to be driven by novel instrument and reagent technologies, as well as from the use of automated modular systems. Developing regions such as APAC and LATAM are expected to be the next growth engines with increasing research and healthcare spending in key countries in the region. However, each country in these regions may differ significantly in their market requirements and may require a bespoke approach combining factors such as widening of sales channels, developing robust service networks, and customized product portfolios.

Key Issues Addressed

  • What is the market size and growth forecast for the qPCR and dPCR segments?
  • Who are the key competitors in this market? How does the competitive landscape look like?
  • What are the key growth opportunities for existing companies and new entrants in this market segment?
  • What changes to the business model are required from companies to cater to changes in market conditions?
  • How is the PCR market evolving? What has been driving M&As in this industry?
  • What are the opportunities and challenges in the high-growth regions?

 

Table of Contents

1. Executive Dashboard
Purpose of this Experiential Study
5-Step Process to Transformational Growth
Strategic Imperatives for Growth
Scope and Segmentation
Market Engineering Measurements—qPCR Instrument Segment
Market Engineering Measurements—dPCR Instrument Segment
Market Engineering Measurements—PCR Reagents Segment
Market Engineering Measurements—PCR Software Segment
Key Findings—How is this Market Important to You?
Big Market Themes
5 Major Growth Opportunities
2. Growth Environment—Market Overview
Methodology
Market Definitions
Vendor Ecosystem
Market Drivers
Market Restraints
3. Growth Environment—Market Forecasts
Revenue Forecast
Revenue Forecast—By Segment
Market Engineering Measurements—qPCR Instrument Segment
Market Engineering Measurements—dPCR Instrument Segment
Revenue Forecast—Instruments
Revenue Forecast—By Instrument Type
Market Engineering Measurements—Reagents
Revenue Forecast—Reagents
Market Engineering Measurements—Software
Revenue Forecast—Software
Market Breakdown—By End User
Regional Analysis
Challenges in High-Growth Developing Economies
4. Visioning Scenarios
qPCR and dPCR Market—Macro to Micro Visioning
qPCR and dPCR Trends—2018 to 2023
Evolution of Business Models—Product-as-a-Solution
Novel Business Models—e-commerce Emerging As Key Sales Driver
Drivers of the e-commerce Based Business Model
Novel Business Models—Integrated Modular PCR-based Solutions
5. Growth Environment—Competitive Playbook
Competitive Environment
qPCR Instrument Segment—Market Share Analysis
dPCR Instrument Segment—Market Tier Analysis
Reagents Segment—Market Share Analysis
Key Companies to Watch
Mergers and Acquisitions in the PCR Industry—Key Trends
Consolidation in Pharmaceutical Industry and Its Impact on the PCR and the Wider Life Sciences Instrumentation Industry
Merger and Acquisition Assessment
6. Growth Pipeline, Strategy, and Implementation
Growth Opportunity Impact Analysis
Growth Opportunity 1—PCR Application in Liquid Biopsy
Growth Opportunity 2—AI to Automate PCR Processes and Analysis
Growth Opportunity 3—PCR for CDx and Precision Medicine
Growth Opportunity 4—Multiplexing and Miniaturization
Growth Opportunity 5—Novel PCR Application and Methodologies
7. The Last Word
Top Predictions for the PCR Market
Legal Disclaimer
8. Appendix
Comparative Matrix of Companies
Additional Sources of Information
List of Exhibits

Infographic



List of Figures & Charts

1. qPCR and dPCR Market: Market Engineering Measurements—qPCR Instrument Segment, Global, 2018
2. qPCR and dPCR Market: Market Engineering Measurements—dPCR Instrument Segment, Global, 2018
3. qPCR and dPCR Market: Market Engineering Measurements—PCR Reagents Segment, Global, 2018
4. qPCR and dPCR Market: Market Engineering Measurements—PCR Software Segment, Global, 2018
5. qPCR and dPCR Market: dPCR Instruments—Company Market Tier Analysis, Global, 2018
6. qPCR and dPCR Market: Reagents—Company Market Tier Analysis, Global, 2018
7. qPCR and dPCR Market: Collaborations, Global, 2017–2018


1. qPCR and dPCR Market: Market Engineering Measurements—qPCR Instrument Segment, Global, 2018
2. qPCR and dPCR Market: Market Engineering Measurements—dPCR Instrument Segment, Global, 2018
3. qPCR and dPCR Market: Market Engineering Measurements—PCR Reagents Segment, Global, 2018
4. qPCR and dPCR Market: Market Engineering Measurements—PCR Software Segment, Global, 2018
5. qPCR and dPCR Market: Vendor Ecosystem, Global, 2018
6. qPCR and dPCR Market: Key Market Drivers, Global, 2019–2023
7. qPCR and dPCR Market: Key Market Restraints, Global, 2019–2023
8. qPCR and dPCR Market: Revenue Forecast, Global, 2017–2023
9. qPCR and dPCR Market: Revenue Forecast by Segment, Global, 2017–2023
10. qPCR and dPCR Market: Instrument Revenue Forecast, Global, 2017–2023
11. qPCR and dPCR Market: Revenue Forecast by Instrument Type, Global, 2017–2023
12. qPCR and dPCR Market: Reagents Revenue Forecast, Global, 2017–2023
13. qPCR and dPCR Market: Software Revenue Forecast, Global, 2017–2023
14. qPCR and dPCR Market: End User Segments, Global, 2018
15. qPCR and dPCR Market: Key Growth Regions, Global, 2018
16. qPCR and dPCR Market: Preferred Purchase Channel for Lab Equipment and Supplies, Global, 2018
17. qPCR and dPCR Market: Competitive Structure, Global, 2018
18. qPCR and dPCR Market: qPCR Instruments Market Share, Global, 2018
19. qPCR and dPCR Market: Reagents Market Share, Global, 2018
20. qPCR and dPCR Market: Growth Opportunity Matrix, Global, 2018



Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.